These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18804989)

  • 1. Adiponectin and cardiovascular risk prediction: can the ambiguities be resolved?
    Wannamethee SG
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):581-4. PubMed ID: 18804989
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
    Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
    Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease.
    Jurado J; Ybarra J; Ferrandiz M; Comerma L; Pou JM
    Diabetes Care; 2007 Aug; 30(8):e86. PubMed ID: 17855271
    [No Abstract]   [Full Text] [Related]  

  • 4. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Aso Y; Mittermayer F; Inukai T; Brix J; Schernthaner G
    Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?
    Bolliger D; Seeberger MD; Filipovic M
    J Am Coll Cardiol; 2009 Oct; 54(17):1607-8. PubMed ID: 19833259
    [No Abstract]   [Full Text] [Related]  

  • 6. The high-molecular weight (HMW) form of adiponectin is a significant surrogate marker for the prediction of type 2 diabetes mellitus in the Japanese population.
    Satoh H; Fujii S; Tsutsui H
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):e9-10. PubMed ID: 19695856
    [No Abstract]   [Full Text] [Related]  

  • 7. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of adiponectin on type 2 diabetes mellitus and cardiovascular disease].
    Chen LH; Li WD
    Yao Xue Xue Bao; 2006 Nov; 41(11):1034-7. PubMed ID: 17262943
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption.
    Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C
    J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative cardiovascular risk evaluation--diagnosis].
    Cremers B; Maack C; Böhm M
    Dtsch Med Wochenschr; 2004 May; 129(22):1256-9. PubMed ID: 15170583
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
    Kawano J; Arora R
    J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum high-molecular weight adiponectin is related to early postprandial glycemic increases and gastric emptying in patients with type 2 diabetes mellitus.
    Iwase M; Iino K; Oku M; Nohara S; Asano T; Doi Y; Iida M
    Diabetes Metab Res Rev; 2009 May; 25(4):344-50. PubMed ID: 19330879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NASH and cardiovascular biomarkers.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A; Tapan S
    Obesity (Silver Spring); 2009 Apr; 17(4):627; author reply 627. PubMed ID: 19322144
    [No Abstract]   [Full Text] [Related]  

  • 16. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk assessment in type 2 diabetes mellitus.
    Al-Ozairi E; Middelbeek RJ; Horton ES
    Curr Diab Rep; 2006 Nov; 6(5):333-6. PubMed ID: 17076992
    [No Abstract]   [Full Text] [Related]  

  • 18. Battlescarred: subgroup or selection bias?
    Lainscak M; von Haehling S; Anker SD
    J Am Coll Cardiol; 2010 Oct; 56(18):1514. PubMed ID: 20951331
    [No Abstract]   [Full Text] [Related]  

  • 19. Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia.
    Iwase M; Iino K; Doi Y; Asano T; Iida M
    Diabetes Res Clin Pract; 2008 Dec; 82(3):e19-22. PubMed ID: 18849086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin: a promising marker for cardiovascular disease.
    Pischon T; Rimm EB
    Clin Chem; 2006 May; 52(5):797-9. PubMed ID: 16638954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.